(Q52007375)

English

Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis.

scientific article published in July 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

author name string

G G Krueger

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

17 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

17-24

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

Inflammatory skin diseases, T cells, and immune surveillance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.4.X

21 January 2018

Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.4.X

21 January 2018

The risk of melanoma in association with long-term exposure to PUVA.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.4.X

21 January 2018

Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.4.X

21 January 2018

The immunologic basis for the treatment of psoriasis with new biologic agents

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.4.X

21 January 2018

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.4.X

21 January 2018

Long-term safety of cyclosporine in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-3083.17.S2.4.X

21 January 2018

Identifiers

10.1046/J.1468-3083.17.S2.4.X

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

release_iai4c5opbreatlbgyvjfyb6ncu

1 reference

https://api.fatcat.wiki/v0/release/iai4c5opbreatlbgyvjfyb6ncu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/12795771

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52007375&oldid=1837293787"